Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Feb 24, 2015, during market hours
10-K filed Feb 24, 2015, 55 days after period end · 0001396814-15-000003
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $197.67M | $33.56M | $10.45M | $4.23M |
| Net Income | -$13.72M | -$11.96M | -$16.35M | -$15.28M |
| EPS Diluted |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.36 |
| -$0.50 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.